Synaptic mitochondria are crucial for maintaining synaptic activity due to their high energy
requirements, substantial calcium (Ca 2+) fluctuation, and neurotransmitter release at the …

Alzheimer's disease (AD) is an age-related progressive neurodegenerative disorder that
leads to cognitive impairment and memory loss. Emerging evidence suggests that …

GluN2B-induced activation of NMDA receptors plays a key function in central nervous
system (CNS) disorders, including Parkinson, Alzheimer, and stroke, as it is strongly …

Alzheimer's disease (AD) is a progressive neurodegenerative disease for which there is a
lack of effective therapeutic drugs. There is great potential for natural products to be used in …

Alzheimer's Disease (AD) is a global public health priority characterized by high mortality
rates in adults and an increasing prevalence in aging populations worldwide. Despite …

Background Raddeanin A is a triterpenoid isolated from Anemone raddeana Regel. It
exhibits a broad spectrum of biological activities such as anti-tumor and anti-inflammatory …

Background Due to the rapid increase in aging population, there has been a rise in cases of
neurodegenerative diseases (NDs), which is a major challenge for human health …

Alzheimer's disease (AD) is a chronic neurological condition that has become a leading
cause of cognitive decline in elder individuals. Hardly any effective medication has been …

Background and Purpose Subjective cognitive decline (SCD) is recognized as a preclinical
indicator of Alzheimer's disease (AD), and this stage provides a valuable time window for …

Alzheimer's disease (AD) stands as the predominant form of dementia, presenting significant
and escalating global challenges. Its etiology is intricate and diverse, stemming from a …